InVivo Therapeutics Holdings Corp. (NVIV): Price and Financial Metrics
GET POWR RATINGS... FREE!
NVIV Stock Price Chart Interactive Chart >
NVIV Price/Volume Stats
| Current price | $2.34 | 52-week high | $13.77 |
| Prev. close | $2.38 | 52-week low | $1.61 |
| Day low | $2.31 | Volume | 16,900 |
| Day high | $2.41 | Avg. volume | 60,067 |
| 50-day MA | $2.18 | Dividend yield | N/A |
| 200-day MA | $3.96 | Market Cap | 4.48M |
InVivo Therapeutics Holdings Corp. (NVIV) Company Bio
InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 and is based in Cambridge, Massachusetts.
Latest NVIV News From Around the Web
Below are the latest news stories about INVIVO THERAPEUTICS HOLDINGS CORP that investors may wish to consider to help them evaluate NVIV as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayWe're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's time to start closing out the trading week with a dive into the biggest pre-market stock movers for Friday morning! |
InVivo Therapeutics Announces Closing of $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq RulesCAMBRIDGE, Mass, October 11, 2022--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that it has closed its previously announced registered direct offering for the sale and issuance of 154,000 shares of the Company’s common stock and pre-funded warrants to purchase up to 369,810 shares of common stock to a single healthcare-focused institutional investor. T |
InVivo Therapeutics Holdings Corp.’s (NASDAQ:NVIV) Stock Is Down -49.25%, But Is It Capable Of A Rally?InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) traded at $4.05 at close of the session on Friday, 10/07/22, made a downward move of -49.25% on its previous day’s price. Looking at the stock we see that its previous close was $7.98 and the beta (5Y monthly) reads 1.29 with the day’s price range being $4.02 – $6.05. … InVivo Therapeutics Holdings Corp.’s (NASDAQ:NVIV) Stock Is Down -49.25%, But Is It Capable Of A Rally? Read More » |
Visa, FTX Team Up to Launch Crypto Debit Card in 40 CountriesVisa (V) stock is on the move following news that it and FTX are teaming up to bring debit cards tied to crypto accounts to more countries. |
NVIV Price Returns
| 1-mo | -2.09% |
| 3-mo | 14.71% |
| 6-mo | -69.49% |
| 1-year | -74.52% |
| 3-year | -98.54% |
| 5-year | -99.98% |
| YTD | -0.43% |
| 2022 | -79.39% |
| 2021 | -43.69% |
| 2020 | -87.99% |
| 2019 | -85.11% |
| 2018 | -92.16% |
Loading social stream, please wait...